Park Amanda, Rome Sandra, Gantioque Raymond
Cedars-Sinai Medical Center.
California State University in Los Angeles.
Clin J Oncol Nurs. 2019 Aug 1;23(4):364-369. doi: 10.1188/19.CJON.364-369.
Jehovah's Witnesses are members of a religion that prohibits them from accepting blood product transfusions. This refusal makes them a particularly compelling population in the context of hematologic malignancies and stem cell transplantation, because blood product transfusions are a mainstay of supportive treatment.
This article presents preventive and supportive measures allowing Jehovah's Witness patients the opportunity to receive a stem cell transplantation without blood product transfusions.
A literature review was done that included evidence focusing on optimizing hematopoiesis, blood loss prevention, alterations in chemotherapy regimens, and implications for nursing practice.
With proper preventive and supportive care measures, Jehovah's Witness patients can receive stem cell transplantations for hematologic malignancies without blood product transfusions.
耶和华见证人是一个宗教团体，其教义禁止他们接受血液制品输血。在血液系统恶性肿瘤和干细胞移植的背景下，这种拒绝使得他们成为一个特别引人关注的群体，因为血液制品输血是支持性治疗的主要手段。
本文介绍了预防和支持措施，使耶和华见证人患者有机会在不接受血液制品输血的情况下接受干细胞移植。
进行了一项文献综述，其中包括侧重于优化造血功能、预防失血、化疗方案改变以及对护理实践影响的证据。
通过适当的预防和支持性护理措施，耶和华见证人患者可以在不接受血液制品输血的情况下接受血液系统恶性肿瘤的干细胞移植。
